Víctor L Cruz (Victor L Cruz)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Endothelial Cells

Loop Mediated Isothermal Amplification

Top Venues

International journal of molecular sciences

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Víctor L Cruz, Virginia Souza-Egipsy, María Gion, José Pérez-García, Javier Cortes, Javier Ramos, Juan F Vega
Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain. International journal of molecular sciences 24 (15) (2023)
Víctor L Cruz, Javier Ramos, Javier Martinez-Salazar, Manuel Montalban-Lopez, Mercedes Maqueda
The Role of Key Amino Acids in the Antimicrobial Mechanism of a Bacteriocin Model Revealed by Molecular Simulations. Journal of chemical information and modeling (2021)